Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
---|
11/13/1996 | EP0741740A1 Method of preparing unsymmetrical phosphoric acid diesters and salts |
11/13/1996 | CN1033272C Method of producing 5'-nucleotide |
11/12/1996 | US5574149 Method of treating HIV infections with 2',3'-dideoxy-3'-fluoro-5-chlorouridine |
11/12/1996 | US5574148 Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides |
11/12/1996 | US5574146 Oligonucleotide synthesis with substituted aryl carboxylic acids as activators |
11/12/1996 | US5574058 Polysubstituted benzimidazoles as antiviral agents |
11/12/1996 | US5574021 Methods of treatment using 2',3'-dideoxy-2',2'-difluoronucleosides |
11/12/1996 | US5573946 Biologically pure culture of Streptomyces hygroscopicus ATCC 53718 capable of producing antibiotic compounds |
11/07/1996 | WO1996034876A1 Nucleic acid ligand complexes |
11/06/1996 | CN1033227C Method for prepn. of pyrimidine nucleoside derivatives having anti-tumor activity |
11/05/1996 | US5571937 Complementary DNA and toxins |
11/05/1996 | US5571902 Synthesis of oligonucleotides |
11/05/1996 | US5571799 (2'-5') oligoadenylate analogues useful as inhibitors of host-v5.-graft response |
11/05/1996 | US5571670 Nucleic acid probes useful in detecting Chlamydia trachomatis and amplified nucleic acid hybridization assays using same |
11/05/1996 | US5571524 Diadenosine tetraphosphate |
10/30/1996 | EP0739902A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents |
10/30/1996 | EP0739901A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents |
10/30/1996 | EP0739900A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents |
10/30/1996 | EP0739899A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents |
10/30/1996 | EP0739898A2 Phosphonomonoester nucleic acids, methods for their preparation and their use |
10/29/1996 | US5569650 Dehydrogenase enzyme inhibitor |
10/24/1996 | WO1996033203A1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
10/24/1996 | WO1996033200A1 Novel compounds and methods for therapy |
10/23/1996 | EP0738274A1 Novel nucleoside-lipid addition compounds, their production and their pharmaceutical use |
10/23/1996 | EP0738273A1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine |
10/23/1996 | EP0738272A1 Method and separation substrate for analysing mononucleotides and oligonucleotides |
10/22/1996 | US5567720 Pharmaceutically active agents that impede amyloid formation in vivo |
10/22/1996 | US5567688 L-nucleosides for the treatment of hepatitis B-virus |
10/22/1996 | US5567588 Forming nucleic acid-target complexes; partitioning increased affinity nucleic acids; amplification |
10/17/1996 | WO1996032496A2 Covalently linked oligonucleotide minor groove binder conjugates |
10/17/1996 | WO1996032404A1 Amphiphilic polyene macrolide antibiotic compounds |
10/17/1996 | WO1996032403A2 Novel cytosine and cytidine derivatives |
10/17/1996 | DE19514523A1 Neue Cytosin- und Cytidinderivate New cytosine and Cytidinderivate |
10/16/1996 | EP0737232A1 Modular design and synthesis of aminimide containing molecules |
10/16/1996 | EP0737201A1 Backbone modified oligonucleotide analogs and solid phase synthesis thereof |
10/15/1996 | US5565559 Culturing an fr-900506; protecting; salt formation; oxidation; reduction; deprotecting |
10/15/1996 | US5565555 Oligonucleotide synthesis; viricides; anticarcinogenic agents; medical diagnosis |
10/15/1996 | US5565438 L-nucleosides for the treatment of epstein-bar virus |
10/15/1996 | US5565437 Aids treatment |
10/15/1996 | US5565359 Cultures for production of B avermectins |
10/10/1996 | WO1996031523A1 Covalently cross-linked oligonucleotides, method for preparing same, and synthon used therein |
10/10/1996 | WO1996031520A2 Novel method of producing nucleosides |
10/10/1996 | WO1996031515A1 Selected soluble esters of hydroxyl-containing indolocarbazoles |
10/10/1996 | WO1996031514A1 Ascomycins |
10/10/1996 | DE19513330A1 Neues Verfahren zur Herstellung von Nucleosiden New process for the preparation of nucleosides |
10/10/1996 | CA2216562A1 Ascomycins |
10/10/1996 | CA2215111A1 Selected soluble esters of hydroxyl-containing indolocarbazoles |
10/09/1996 | EP0735888A1 Purine compositions and methods for administration |
10/08/1996 | US5563257 Phospholipid derivatives of nucleosides |
10/08/1996 | US5563172 Macrocyclic amide and urea immunomodulators |
10/08/1996 | US5563135 Immunosuppressive agent |
10/08/1996 | US5563125 5'-deoxy-5'-(substituted)alkylthioribose compounds and their pharmaceutical compositions |
10/08/1996 | US5563049 Culture product |
10/03/1996 | WO1996030369A1 Process for the synthesis of nucleoside analogues |
10/03/1996 | WO1996030025A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
10/02/1996 | EP0735045A1 Process for the preparation of 2,2'-andhydro- and 2'-keto-1-(3',5'-di-o-protected-beta -d-arabinofuranosyl) nucleosides |
10/02/1996 | EP0735044A1 Preparation of D4T from 5-methyluridine |
10/02/1996 | EP0735043A1 Process for the preparation of a 2-substituted-3,3-difluorofuran |
10/02/1996 | EP0734391A1 Pna-dna-pna chimeric macromolecules |
10/02/1996 | CN1132529A DNA sequencing enzymes |
10/02/1996 | CN1132513A Process and antiparasitic intermediates for doramectin |
10/02/1996 | CN1132073A 1,3-oxathiolane nucleoside analogues |
10/01/1996 | US5561228 Immunosuppressnats; side effect reduction |
10/01/1996 | US5561225 Phosphorus-free nucleotides, oligonucleotides and polynucleotides having sulfonate or sulfonamide linkages; antisense agents; anticarcinogenic agents; parasiticides; genetic probes; hiv |
10/01/1996 | US5561137 Immunosuppressants; side effect reduction |
10/01/1996 | US5561134 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
10/01/1996 | US5561120 Low toxicity to host cells |
09/26/1996 | WO1996029345A1 Novel inotropic agents |
09/26/1996 | WO1996029336A1 Chemical compounds |
09/25/1996 | EP0733630A1 Nucleoside derivative |
09/25/1996 | EP0733214A1 Dense microsphere components derived from mammalian brain tissue and antibodies thereto |
09/25/1996 | EP0733119A1 Method of producing derivatives of lactosamine |
09/25/1996 | CA2171522A1 Process for the preparation of a 2-substituted-3, 3-difluorofuran |
09/25/1996 | CA2171518A1 Process for the preparation of 2,2'-anhydro- and 2' -keto-1-(3', 5'-di-o-protected-.beta.-d-arabinofuranosyl) nucleosides |
09/24/1996 | US5559222 Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose |
09/24/1996 | US5559102 Adenosine and guanosine-3'-5'-cyclic methylphosphonate derivatives |
09/24/1996 | US5559101 Antitumor, anticarcinogenic, hiv |
09/24/1996 | US5559100 Viricides using aminopurine bases |
09/24/1996 | US5558991 DNA sequencing method using acyclonucleoside triphosphates |
09/24/1996 | US5558986 Method and kit for ATP assays using cyclodextrin |
09/19/1996 | WO1996028457A1 Nucleic acid synthesis using photoremovable protecting groups |
09/19/1996 | WO1996028438A1 Non-nucleosidic coumarin derivatives as polynucleotide-cross-linking agents |
09/19/1996 | WO1996028170A1 Reduced toxicity compositions and methods for treating hiv infections |
09/19/1996 | WO1996028163A1 Adenosine as a positive inotrop in the compromised heart |
09/19/1996 | WO1996018736A3 Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses |
09/19/1996 | CA2215657A1 Nucleic acid synthesis using photoremovable protecting groups |
09/19/1996 | CA2214835A1 Non-nucleosidic coumarin derivatives as polynucleotide-cross-linking agents |
09/19/1996 | CA2213749A1 Adenosine as a positive inotrop in the compromised heart |
09/18/1996 | EP0732338A1 2,2-Difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides |
09/18/1996 | EP0731808A1 Nucleosides and oligonucleotides containing boron clusters |
09/18/1996 | EP0731807A1 N-2 substituted purines |
09/17/1996 | US5556975 Cyclic gmp phosphodiesterase inhibitor |
09/17/1996 | US5556961 Nucleosides with 5'-O-photolabile protecting groups |
09/17/1996 | US5556868 Antiparasitic avermectin and milbemycin derivatives |
09/12/1996 | WO1996027606A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
09/12/1996 | WO1996027605A1 Systematic evolution of ligands by exponential enrichment: chemi-selex |
09/12/1996 | WO1996027380A1 Reduction of infarct volume using citicoline |
09/12/1996 | CA2213000A1 Reduction of infarct volume using citicoline |
09/12/1996 | CA2209665A1 Systematic evolution of ligands by exponential enrichment: chemi-selex |
09/11/1996 | EP0542952B1 Use of 1-(beta-d-arabinofuranosyl)-5-propynyluracil for lowering serum cholesterol |